In contrast, free CDN activated not only monocytes (EC50 ~0.06 μM), but at higher drug concentrations (required for anti-tumor activity) also activated T cells (EC50 ~3.6 μM) and NK cells (EC50 ~2.4 μM) (Fig. 6b). The gene discussed is NT5C; the disease is neoplasm.